Abstract Details

Title Pregnancy Outcome and Teriflunomide Treatment Exposure for Relapsing Remitting Multiple Sclerosis A 4 year follow up

Topic Multiple Sclerosis

Presentation(s) P1 - (-)

Poster/Presentation
Number 359

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Clementine Karageorgiou, MD (Neurological Institute of Athens) PRESENTER	The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Asimina Athanasouli	Asimina Athanasouli has nothing to disclose.
Themistokles Kalamatas (General Anthens Hospital)	No disclosure on file

��ɫ��